CFR Pharmaceuticals Subscribes Allergy Therapeutics Fundraising
Apr 19, 2012
CFR Pharmaceuticals announces the acquisition of 50.0% of the Indian laboratory Stellence Pharmscience
Apr 04, 2012
Apr 23, 2012
Apr 20, 2012
Mar 15, 2012